Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Spotify debut boosts markets By: MarketMinute.com Market Updates April 03, 2018 at 19:14 PM EDT Spotify's impressive market debut boosted investor enthusiasm to lift the markets to a sharply higher close with the Dow surging 389 points to 24,033. Nasdaq leaped 71 points to 6941.On the upsideShares of Spotify (NYSE: SPOT) soared on its first trading day. Allogene Therapeutics will assume the strategic collaboration and license agreement that Pfizer (NYSE: PFE) had with Cellectis (Nasdaq: CLLS) to develop "off-the-shelf" CAR T immunotherapies for oncology.Bargain hunters lifted shares of Sunlands Online Education Group (NYSE: STG). On the downside Investors locked in profits on Limelight Networks (Nasdaq: LLNW).Rigel Pharmaceuticals (Nasdaq: RIGL) reported disappointing Phase 2 study results.Seeking Alpha wrote that Nova Lifestyle (Nasdaq: NVFY) has key unresolved issues.In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 climbed 32 points to 2,614. Bitcoin fell $30 to $7,403. Related Stocks: Cellectis S.A. ADR Limelight Networks NDX Nova Lifestyle Inc Pfizer Rigel Pharmaceuticals Spotify Technology S.A. Sunlands Online Education Group ADR Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Spotify debut boosts markets By: MarketMinute.com Market Updates April 03, 2018 at 19:14 PM EDT Spotify's impressive market debut boosted investor enthusiasm to lift the markets to a sharply higher close with the Dow surging 389 points to 24,033. Nasdaq leaped 71 points to 6941.On the upsideShares of Spotify (NYSE: SPOT) soared on its first trading day. Allogene Therapeutics will assume the strategic collaboration and license agreement that Pfizer (NYSE: PFE) had with Cellectis (Nasdaq: CLLS) to develop "off-the-shelf" CAR T immunotherapies for oncology.Bargain hunters lifted shares of Sunlands Online Education Group (NYSE: STG). On the downside Investors locked in profits on Limelight Networks (Nasdaq: LLNW).Rigel Pharmaceuticals (Nasdaq: RIGL) reported disappointing Phase 2 study results.Seeking Alpha wrote that Nova Lifestyle (Nasdaq: NVFY) has key unresolved issues.In the broad market, advancing issues outpaced decliners by a margin of more than 5 to 2 on the NYSE and by nearly 2 to 1 on Nasdaq. The broader S&P 500 climbed 32 points to 2,614. Bitcoin fell $30 to $7,403. Related Stocks: Cellectis S.A. ADR Limelight Networks NDX Nova Lifestyle Inc Pfizer Rigel Pharmaceuticals Spotify Technology S.A. Sunlands Online Education Group ADR